Tetra Technologies (NYSE:TTI) reported quarterly sales of $113.15 million which beat the analyst consensus estimate of $108.30 million by 4.48 percent. This is a 49.95 percent increase over sales of $75.46 million the same period last year.
Teva Stops Production At US Plant After FDA Concerns: Report
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has temporarily stopped drug production at its Irvine plant in California to address issues raised by…
